Drug Class: Antineoplastics and Related Agents
Dosage Form: Powder for Injection
Strength: 15mg
Indications/Special comments: Adjunct to surgery and radiotherapy in palliative treatment of Hodgkin and non-Hodgkin lymphomas; reticulum cell sarcoma and lymphoma; carcinomas of the head, neck, larynx, cervix, penis, skin, vulva, testicles and including embryonal cell carcinoma, choriocarcinoma and teratoma; malignant effusions.
Dosage Administration: Adult and Child: Single agent therapy: I.M, I.V, SC: Squamous cell carcinoma, lymphoma, testicular carcinoma: 0.25 - 0.5 units/kg (10 - 20 units/m2) 1 - 2 times/week. Combination agent therapy: I.M, I.V: 3 - 4 units/m2. I.V: ABVD: 10 units/m2 on days 1 and 15. Pleural sclerosing: 60 - 240 units as a single infusion.